GSK GSK plc

FRANKFURT--The following is a summary of analysts' forecasts for Glaxosmithkline plc (GSK.LN) first-quarter results, based on a poll of eight analysts conducted by Dow Jones Newswires (figures in million pound, EPS, dividend and target price in pence, according to IFRS). Earnings figures are scheduled to be released April 27.

=== 
                           Core:            -Net 
                Turnover   operat.        attrib. 
1st Quarter        total   profit   -PBT  profit   -EPS 
AVERAGE            5,998    1,447  1,285     881   18.2 
Prev. Year         5,622    1,305  1,156     834   17.3 
+/- in %            +6.7      +11    +11    +5.7   +5.2 
 
MEDIAN             5,999    1,446  1,278     881   18.2 
Maximum            6,108    1,510  1,348     939   19.4 
Minimum            5,836    1,395  1,246     844   17.5 
Amount                 8        8      7       7      8 
 
Bernstein          6,015    1,458  1,278     881   18.2 
Cowen and Company  5,985    1,425  1,260     893   18.4 
Deutsche Bank      6,012    1,447  1,278     854   17.6 
Exane BNP Paribas  5,977    1,445     --      --   18.2 
Jefferies          6,076    1,415  1,259     858   17.7 
Morgan Stanley     6,108    1,484  1,325     900   18.6 
Oddo Securities    5,836    1,395  1,246     844   17.5 
UBS                5,973    1,510  1,348     939   19.4 
 
            Target price    Rating                 DPS 2016 
AVERAGE            1,464    positive 0   AVERAGE       80.0 
Prev. Quarter      1,468    neutral  7   Prev. Year   100.0 
+/- in %            -0.2    negative 1   +/- in %       -20 
 
MEDIAN             1,463                 MEDIAN        80.0 
Maximum            1,550                 Maximum       80.0 
Minimum            1,350                 Minimum       80.0 
Amount                 6                 Amount           5 
 
Bernstein          1,496    Market perform               -- 
Cowen and Company     --    Market perform             80.0 
Deutsche Bank      1,540    Hold                       80.0 
Exane BNP Paribas  1,430    Neutral                    80.0 
Jefferies          1,550    Hold                       80.0 
JP Morgan             --    Neutral                      -- 
Oddo Securities    1,350    Reduce                     80.0 
UBS                1,420    Neutral                      -- 
=== 

Year-earlier figures are as reported by the company.

DJG/err 

(END) Dow Jones Newswires

April 22, 2016 07:19 ET (11:19 GMT)

GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024

GSK (NYSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024